[1]张成宪,李芳玲,马 莹.腹水肿瘤标记物对良恶性腹水的鉴别诊断价值[J].医学信息,2020,(11):173-174.[doi:10.3969/j.issn.1006-1959.2020.11.057]
 ZHANG Cheng-xian,LI Fang-ling,MA Ying.Differential Diagnosis Value of Ascites Tumor Markers for Benign and Malignant Ascites[J].Medical Information,2020,(11):173-174.[doi:10.3969/j.issn.1006-1959.2020.11.057]
点击复制

腹水肿瘤标记物对良恶性腹水的鉴别诊断价值()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2020年11期
页码:
173-174
栏目:
诊疗技术
出版日期:
2020-06-01

文章信息/Info

Title:
Differential Diagnosis Value of Ascites Tumor Markers for Benign and Malignant Ascites
文章编号:
1006-1959(2020)11-0173-02
作者:
张成宪李芳玲马 莹
(庆阳市人民医院检验科,甘肃 庆阳 745000)
Author(s):
ZHANG Cheng-xianLI Fang-lingMA Ying
(Department of Laboratory,Qingyang People’s Hospital,Qingyang 745000,Gansu,China)
关键词:
腹水肿瘤标志物诊断价值
Keywords:
AscitesTumor markersDiagnostic value
分类号:
R730.6
DOI:
10.3969/j.issn.1006-1959.2020.11.057
文献标志码:
A
摘要:
目的 探讨腹水肿瘤标志物在良恶性腹水鉴别诊断中的应用价值。方法 选取2017年6月~2019年6月庆阳市人民医院收治的30例肿瘤疾病伴腹水患者为恶性组,另选择同期住院的45例相应良性疾病伴腹水患者为良性组,比较两组腹水肿瘤标志物水平,并采用ROC曲线分析恶性组腹水肿瘤标志物(CEA、CA125、CA153、CA199、铁蛋白、AFP、SCC)的诊断价值。结果恶性组腹水肿瘤标志物CEA、CA125、CA153、CA199、铁蛋白、AFP水平高于良性组,差异有统计学意义(P<0.05);两组SCC水平比较,差异无统计学意义(P>0.05)。恶性组腹水肿瘤标志物CEA、SCC、CA125、CA153、CA199、铁蛋白、AFP的ROC曲线下面积分别为0.885、0.691、0.815、0.934、0.685、0.771、0.759。结论 腹水肿瘤标志物CEA、CA125、CA153、铁蛋白、AFP在恶性腹水的鉴别诊断中均具较高的诊断价值。
Abstract:
Objective To explore the application value of ascites tumor markers in the differential diagnosis of benign and malignant ascites.Methods 30 patients with tumor disease and ascites admitted to Qingyang People’s Hospital from June 2017 to June 2019 were selected as the malignant group, and 45 patients with benign disease and ascites hospitalized in the same period were selected as the benign group, compare the levels of ascites tumor markers between the two groups, the ROC curve was used to analyze the diagnostic value of ascites tumor markers (CEA, CA125, CA153, CA199, ferritin, AFP, SCC) in malignant group.Results The levels of ascites tumor markers CEA, CA125, CA153, CA199, ferritin, and AFP in the malignant group were higher than those in the benign group,the difference was statistically significant (P<0.05); the SCC levels in the two groups were not statistically significant (P>0.05).The areas under the ROC curve of the ascites tumor markers CEA, SCC, CA125, CA153, CA199, ferritin, and AFP in the malignant group were 0.885, 0.691, 0.815, 0.934, 0.685, 0.771, and 0.759, respectively.Conclusion The ascites tumor markers CEA, CA125, CA153, ferritin and AFP have high diagnostic value in the differential diagnosis of malignant ascites.

参考文献/References:

[1]吴鹏飞,王根和.恩度联合顺铂与单药顺铂灌注治疗恶性腹 水的临床观察[J].齐齐哈尔医学院学报,2015,32(35):5335-5337.[2]窦倩,商海涛,叶进,等.血清及腹水肿瘤标志物对良恶性腹水的鉴别诊断价值[J].华中科技大学学报(医学版),2014(1):104-107.[3]王天涛.细胞形态学检查在鉴别良恶性胸腹水细胞中的应用[J].临床检验杂志(电子版),2019,8(3):83-84.[4]林菊.胸腹水与血液中生化指标联合检测对良恶性胸腹水鉴别的诊断价值[J].中国继续医学教育,2016,8(10):42-43.[5]Orlandi R,De Bortoli M,Ciniselli CM,et al.Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer[J].Ann Oncol,2014,25(2):352-357.

相似文献/References:

[1]钟 磊,谢海燕,林 霖.电化学发光免疫分析技术检测肿瘤标志物在乳腺癌诊断中的应用[J].医学信息,2018,(20):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
 ZHONG Lei,XIE Hai-yan,LIN Lin.Application of Electrochemiluminescence Immunoassay for Detection of Tumor Markers in Diagnosis of Breast Cancer[J].Medical Information,2018,(11):155.[doi:10.3969/j.issn.1006-1959.2018.20.048]
[2]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
 LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,(11):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[3]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
 WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Medical Information,2019,(11):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[4]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
 YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Medical Information,2019,(11):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
[5]杨天敬,李 然,苏卫东.CA153、CA125联合HER-2检测在乳腺癌各临床分期诊断中的应用[J].医学信息,2020,(07):173.[doi:10.3969/j.issn.1006-1959.2020.07.058]
 YANG Tian-jing,LI Ran,SU Wei-dong.Application of CA153 and CA125 Combined with HER-2 Detection in the Diagnosis of Breast Cancer in Different Clinical Stages[J].Medical Information,2020,(11):173.[doi:10.3969/j.issn.1006-1959.2020.07.058]
[6]刘瀚予,贾莉莉,喻文立,等.外泌体在肝癌中的作用机制研究进展[J].医学信息,2020,(08):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]
 LIU Han-yu,JIA Li-li,YU Wen-li,et al.The Mechanism of Exosomes in Liver Cancer[J].Medical Information,2020,(11):26.[doi:10.3969/j.issn.1006-1959.2020.08.010]

更新日期/Last Update: 1900-01-01